Characterization of two Bacillus probiotics.
Bacillus subtilis is currently used as an oral probiotic. We examined two commercial B. subtilis probiotic preparations, Enterogermina and Biosubtyl. Surprisingly, physiological and genetic characterization of the bacteria contained in each of these preparations has shown that neither contains B. subtilis.
Green
D H
DH
School of Biological Sciences, Royal Holloway University of London, Egham, Surrey TW20 0EX, United Kingdom.
Wakeley
P R
PR
Page
A
A
Barnes
A
A
Baccigalupi
L
L
Ricca
E
E
Cutting
S M
SM
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001407:Bacillus / Q000145:classification / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D001412:Bacillus subtilis / Q000145:classification / Q000187:drug effects / Q000254:growth & development / Q000502:physiology*; D004352:Drug Resistance, Microbial; D016133:Polymerase Chain Reaction; D019936:Probiotics; D012336:RNA, Ribosomal, 16S / Q000235:genetics; D017422:Sequence Analysis, DNA; D013171:Spores, Bacterial / Q000502:physiology
D000900:Anti-Bacterial Agents; D012336:RNA, Ribosomal, 16S